Evidence map›Paper›PMID 23236235›Full record

ArticleWorld journal of gastroenterology2012

Hepatoprotective effects of baicalein against CCl₄-induced acute liver injury in mice.

Hai-Li Huang, Ya-Jing Wang, Qing-Yu Zhang, Bin Liu, Fang-Yuan Wang, Jing-Jing Li, Run-Zhi Zhu

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Chlorogenic Acid Ameliorates CClAnti-cancer agents in medicinal chemistry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Chemical Composition ofMolecules (Basel, Switzerland) · 2022
    Article
  14. Hepatoprotective Polysaccharides fromMolecules (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Review
  17. Protective Effect ofNutrients · 2021
    Article
  18. Article
  19. Review
  20. 5-O-Demethylnobiletin Alleviates CClInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hai-Li HuangLaboratory of Regenerative Medicine, Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, Guangdong Province, China.
Ya-Jing Wang
Qing-Yu Zhang
Bin Liu
Fang-Yuan Wang
Jing-Jing Li
Run-Zhi Zhu
Guangdong Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the hepatoprotective effect of baicalein against carbon tetrachloride (CCl₄)-induced liver damage in mice.

methodsMice were orally administered with baicalein after CCl₄ injection, and therapeutic baicalein was given twice a day for 4 d. The anti-inflammation effects of baicalein were assessed directly by hepatic histology and serum alanine aminotranferease and aspartate aminotransferase measurement. Proliferating cell nuclear antigen was used to evaluate the effect of baicalein in promoting hepatocyte proliferation. Serum interleukin (IL)-6, IL-1β and tumor necrosis factor-α (TNF-α) levels were measured by enzyme-linked immunosorbent assay and liver IL-6, TNF-α, transforming growth factor-α (TGF-α), hepatocyte growth factor (HGF) and epidermal growth factor (EGF) genes expression were determined by quantitative real-time polymerase chain reaction.

resultsCCl₄-induced acute liver failure model offers a survival benefit in baicalein-treated mice. The data indicated that the mRNA levels of IL-6 and TNF-α significantly increased within 12 h after CCl₄ treatment in baicalein administration groups, but at 24, 48 and 72 h, the expression of IL-6 and TNF-α was kept at lower levels compared with the control. The expression of TGF-α, HGF and EGF was enhanced dramatically in baicalein administration group at 12, 24, 48 and 72 h. Furthermore, we found that baicalein significantly elevated the serum level of TNF-α and IL-6 at the early phase, which indicated that baicalein could facilitate the initiating events in liver regeneration.

conclusionBaicalein may be a therapeutic candidate for acute liver injury. Baicalein accelerates liver regeneration by regulating TNF-α and IL-6 mediated pathways.

Indexed as

Alanine TransaminaseAnimalsAnti-Inflammatory AgentsAspartate AminotransferasesCarbon TetrachlorideCell ProliferationFlavanonesHepatocytesInterleukin-1betaInterleukin-6LiverLiver Failure, AcuteMaleMiceMice, Inbred C57BLProliferating Cell Nuclear AntigenAlanine TransaminaseAnti-Inflammatory AgentsAspartate AminotransferasesbaicaleinCarbon TetrachlorideFlavanonesInterleukin-1betaInterleukin-6Proliferating Cell Nuclear AntigenTumor Necrosis Factor-alphaBaicaleinCarbon tetrachlorideHepatocyte proliferationLiver injuryLiver regeneration

Identifiers

PMID23236235
PMCPMC3516202
OpenAlexW2144919352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.